ong-term study of HOB-294 in patients with overactive bladder.
Phase 3
- Conditions
- Overactive bladder
- Registration Number
- JPRN-jRCT2080221273
- Lead Sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patients with symptoms of overactive bladder for at least 24 weeks before obtaining informed consent
Exclusion Criteria
- Patients with genuine stress incontinence
- Patients with micturition difficulty, retention of urine, or other symptoms due to lower urinary tract obstruction
- Patients for whom it is difficult to walk to the lavatory without assistance, patients who cannot measure the urine volume by themselves, and patients who cannot keep a bladder log by themselves
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety, Efficacy
- Secondary Outcome Measures
Name Time Method